Third COVID-19 vaccine dose boosts neutralizing antibodies in poor responders

BACKGROUND: While evaluating COVID-19 vaccine responses using a rapid neutralizing antibody (NAb) test, we observed that 25% of mRNA vaccine recipients did not neutralize >50%. We termed this group “vaccine poor responders” (VPRs). The objective of this study was to determine if individuals who n...

Descripción completa

Detalles Bibliográficos
Autores principales: Lake, Douglas F., Roeder, Alexa J., Gonzalez-Moa, Maria J., Koehler, Megan, Kaleta, Erin, Jasbi, Paniz, Vanderhoof, John, McKechnie, Davis, Forman, Jack, Edwards, Baylee A., Seit-Nebi, Alim, Svarovsky, Sergei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273613/
https://www.ncbi.nlm.nih.gov/pubmed/35832309
http://dx.doi.org/10.1038/s43856-022-00151-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273613/
https://www.ncbi.nlm.nih.gov/pubmed/35832309
http://dx.doi.org/10.1038/s43856-022-00151-2

Ejemplares similares